AMBQ

CIK 0001500412

Small Revenue $73M Assets $436M as of Oct 11, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Want to see a complete report first? Today's free report (NRIX 10-Q) is open in full — no account needed.

10-Q Filed Aug 11, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 11, 2026 · Period ending Aug 11, 2026

Summary not yet generated.

Partner

Trade AMBQ commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

8-K Filed Jul 30, 2026 · Period ending Jul 30, 2026

Summary not yet generated.

S-1 Filed Jun 22, 2026 Red flag

Ambiq Micro files for $162.9M primary offering at $90.48/share, with $152.3M net proceeds

7 material changes detected. Sign up free to read the summary.

View report

8-K Filed Jun 8, 2026 · Period ending Jun 8, 2026

Summary not yet generated.

10-Q Filed May 12, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 11, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(in thousands, except share and per share amounts)

Description	Three months ended June 30, 2026	Three months ended June 30, 2025	Six months ended June 30, 2026	Six months ended June 30, 2025
Net sales	33,901	17,873	58,961	33,605
Cost of sales	18,634	10,703	32,803	18,046
Gross profit	15,267	7,170	26,158	15,559
Operating expenses:
Research and development	14,139	8,898	26,971	17,585
Selling, general and administrative	9,855	7,069	19,603	15,512
Total operating expenses	23,994	15,967	46,574	33,097
Loss from operations	(8,727)	(8,797)	(20,416)	(17,538)
Other income, net	1,613	315	3,134	776
Loss before income taxes	(7,114)	(8,482)	(17,282)	(16,762)
Provision for income taxes	1	14	4	18
Net loss	(7,115)	(8,496)	(17,286)	(16,780)
Net loss per share, basic and diluted	(0.32)	(18.89)	(0.82)	(37.59)
Weighted-average shares used in computing net loss per share, basic and diluted	21,742,929	449,785	21,073,361	446,390
Comprehensive loss:
Currency translation adjustment	124	110	189	80
Comprehensive loss	(6,991)	(8,386)	(17,097)	(16,700)

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except share and per share amounts)

Description	June 30, 2026	December 31, 2025
Assets
Current assets:
Cash and cash equivalents	366,774	140,275
Accounts receivable, net	17,528	7,286
Inventories	29,365	16,937
Prepaid expenses and other current assets	2,958	3,421
Total current assets	416,625	167,919
Property, equipment and software, net of accumulated depreciation and amortization of $15,480 and $14,632, respectively	4,328	4,137
Right-of-use assets, net	3,244	638
Intangible assets, net of accumulated amortization of $13,469 and $10,752, respectively	10,224	11,593
Other assets	1,201	393
Total assets	435,622	184,680
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	10,615	8,577
Accrued and other current liabilities	14,469	10,201
Short-term lease liabilities	1,034	400
Total current liabilities	26,118	19,178
Long-term lease liabilities	3,549	278
Other long-term liabilities	1,283	2,765
Total liabilities	30,950	22,221
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.000001 par value; 500,000,000 shares authorized; 24,146,260 shares and 18,316,928 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	—	—
Additional paid-in capital	778,920	519,610
Accumulated deficit	(373,997)	(356,711)
Accumulated other comprehensive loss	(251)	(440)
Total stockholders’ equity	404,672	162,459
Total liabilities and stockholders’ equity	435,622	184,680

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)

Description	Six months ended June 30, 2026	Six months ended June 30, 2025
Cash flows from operating activities
Net loss	(17,286)	(16,780)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,525	3,814
Stock-based compensation	6,919	1,616
Gain on receipt of nonmonetary tangible assets	—	(1,600)
Change in right-of-use assets	386	510
Change in warrant valuations and cancellations	—	60
Other	—	(110)
Changes in operating assets and liabilities
Accounts receivable	(10,242)	2,705
Inventories	(12,428)	(751)
Prepaid expenses and other assets	931	(1,257)
Other long-term assets	49	(1)
Accounts payable	4,002	874
Accrued and other current liabilities	3,872	446
Other long-term liabilities	(406)	(75)
Net cash used in operating activities	(20,678)	(10,549)
Cash flows from investing activities
Purchase of intangible assets	(5,120)	(2,687)
Purchases of property, equipment and software	(781)	(454)
Net cash used in investing activities	(5,901)	(3,141)
Cash flows from financing activities
Proceeds from issuance of common stock in connection with follow-on offerings, net of underwriting discounts and commissions	245,468	—
Payment of deferred offering costs	(1,542)	—
Proceeds from exercise of stock options	6,099	175
Proceeds from exercise of warrants	3,010	—
Net cash provided by financing activities	253,035	175
Effect of exchange rate changes on cash and cash equivalents	43	39
Net increase (decrease) in cash and cash equivalents	226,499	(13,476)
Cash and cash equivalents at beginning of period	140,275	60,981
Cash and cash equivalents at end of period	366,774	47,505
Supplemental disclosure of non-cash investing and financing activities
Intangible assets in accounts payable, accrued and other long-term liabilities	5,991	8,328
Gain on receipt of nonmonetary tangible assets	—	1,600
Right-of-use assets obtained in exchange for new operating lease liabilities	3,018	383

Amounts as printed on the EDGAR/iXBRL face — (in thousands, except share and per share amounts); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View all filings for AMBQ on SEC EDGAR